# SecondWave Systems

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/secondwave-systems

- Industry: Medical Devices & Equipment
- Headquarters: Minneapolis, US
- Website: www.secondwaveUS.com/
- Total disclosed funding: $7M
- Latest round: Series A (Oct 22, 2025)
- Investors on record: 4

## About

Founded in 2019 and based in Minneapolis, US, SecondWave Systems, Inc. develops noninvasive wearable ultrasound stimulation technology, aimed at improving therapeutic outcomes for patients with various medical conditions by enhancing nerve, cell, and organ function. SecondWave Systems, Inc, and specializes in wearable ultrasound stimulation platforms. The company has conducted one deal so far, with its most recent funding round being a Series A completed on April 8, 2025, raising USD 7.000 mn from investors including Treo Ventures, Scientific Health Development, and the University of Minnesota. The founder's history is currently not stated, and there are no mentions of pivots or subsidiaries. SecondWave Systems specializes in a noninvasive, wearable ultrasound stimulation platform designed to enhance the treatment of various medical conditions. Their core technology employs low-intensity focused ultrasound (LiFU) to modulate nerves, cells, and organs, offering an alternative to traditional medications that often come with significant side effects. The platform aims to provide therapeutic solutions for a range of conditions including inflammation and pain management, catering primarily to patients with debilitating or life-threatening diseases. The product's miniaturized design facilitates in-home self-administration, promoting ease of use and reducing the need for frequent clinical visits. SecondWave's offerings are targeted at healthcare providers and end users primarily in North America and Europe, where there is a growing demand for innovative, low-cost therapeutic options.SecondWave Systems generates revenue through direct-to-consumer sales and partnerships with healthcare providers. The company's business model is structured around the sale of its flagship ultrasound stimulation devices, which are tailored for patient self-administration under medical guidance. Revenue is derived from both individual product sales and potential subscription models for ongoing support and therapy adjustments. The pricing structure is designed to be accessible for patients, encouraging usage while maintaining profitability. The focus on innovative, adaptive therapy solutions positions SecondWave Systems to strengthen its market presence and build robust relationships with healthcare professionals, ultimately aiming to improve patient outcomes and streamline treatment processesIn October 2025, SecondWave Systems, Inc. raised an undisclosed amount of Series A funding from new investor Sectoral Asset Management. The round was part of a larger series A funding, with plans to utilize the funding for further clinical research regarding rheumatoid arthritis. The company aims to develop and launch new products focused on enhancing treatment for various conditions, with specifics on launch dates yet to be disclosed. Additionally, SecondWave plans to expand its market reach, particularly in North America and Europe, leveraging the recent funding to support these initiatives.

## Funding rounds

- Series A, Oct 22, 2025 — Sectoral Asset Management
- Series A, Apr 8, 2025, $7M — University of Minnesota, Scientific Health Development, Treo Ventures

## Investors

- University of Minnesota — Series A
- Scientific Health Development (https://capitalatlas.ai/funds/scientific-health-development) — Series A
- Treo Ventures (https://capitalatlas.ai/funds/treo-ventures) — Series A
- Sectoral Asset Management (https://capitalatlas.ai/funds/sectoral-asset-management) — Series A